logo-loader

Faron Pharmaceuticals Ltd

Market:
AIM
Market Cap:
£107.14 m
Price
247.50 GBX
Change
6.45%
52 weeks high
320.50
52 weeks low
52.29

In brief

Faron is a clinical stage biopharmaceutical company developing novel treatments for medical conditions with significant unmet needs. The Company currently has a pipeline focusing on acute organ traumas, vascular damage and cancer immunotherapy.

Deep dive We explore the investor case for growth companies

Snapshot

  • First-in-person trial underway for Clevegen cancer treatment
  • Patients dosed showed a rise in natural killer cells and T-Cells
  • Patient’s tumour shrank after treatment
  • £7.48mln raised in shares placing to finance phase I/II MATINS trial